Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Large scale interactions in brain networks and their breakdown in brain diseases

BRAINSYNC

The long-term goal of this project is to understand how neuronal assemblies exchange information (functional or neuronal communication), and how variability in neuronal communication explains variability in behavioural performance, both in the intact and injured brain. Communication involves temporal interactions between neuronal assemblies either...

Funding Programme
Start Date
End Date
Total Funding
€ 3 933 811
European Countries Involved

Light-addressable potentiometric sensors (LAPS) for zinc imaging with high spatiotemporal resolution for elucidating the role of zinc in age related macular degeneration.

ZINCLAPS

Light-addressable potentiometric sensors (LAPS) have great potential as a tool for functional electrochemical imaging of the attachment area of cells, providing information such as ion concentration, extracellular potentials and ion channel activity. The technique is particularly attractive for analysing cell responses of cells with planar...

Funding Programme
Start Date
End Date
Total Funding
€ 195 455
European Countries Involved

Loss of neurotrophic factors in neurodegenerative Dementias: Back to the crossroads of proteins

LODE

Neurodegenerative dementias are characterised by a continuous loss of neurons that are not replaced. Why neurons die in disease-affected brain regions is still a matter of discussion. This project explores a key common pathological mechanism across the three major neurodegenerative diseases leading to dementia: Alzheimer’s disease, Frontotemporal...

Funding Programme
Start Date
End Date
Total Funding
€ 1 020 000
European Countries Involved

Magnetic DIagnostic Assay for neurodegenerative diseases

MADIA

MADIA aims at realizing a versatile and cheap diagnostic device based on magnetoresistive sensors, microfluidic device, ultra–small Magnetic Nanoparticles (MNPs) and advanced bio-chemical functionalization methods for the early and ultrasensitive. in vitro detection of biomarkers trustfully associated with 2 incurable neurodegenerative diseases...

Funding Programme
Start Date
End Date
Total Funding
€ 3 891 062
European Countries Involved

Managing active and healthy aging with use of caring service robots

MARIO

MARIO addresses the difficult challenges of loneliness, isolation and dementia in older persons through innovative and multi-faceted inventions delivered by service robots. The effects of these conditions are severe and life-limiting. They burden individuals and societal support systems. Human intervention is costly but the severity can be...

Funding Programme
Start Date
End Date
Total Funding
€ 3 994 857
European Countries Involved

Membrane protein aggregation and its links with neurodegenerative diseases

MPA-ND

Protein aggregation is associated with some of the most prevalent and devastating neurodegenerative disorders in our society, including Alzheimer’s and Parkinson’s diseases. The intricate details of the aggregation process are now beginning to emerge through major efforts for characterizing the associated protein deposits . However, knowledge about...

Funding Programme
Start Date
End Date
Total Funding
€ 183 455
European Countries Involved

Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets

MEMOSAD

MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a...

Funding Programme
Start Date
End Date
Total Funding
€ 4 023 080
European Countries Involved

Memory research: Ground-breaking, Applied, and Technological Exchanges

M-GATE

In M-GATE, ESRs will combine state-of-the art experimental neurophysiology, innovative technologies, and advanced theoretical approaches to unveil memory mechanisms, from single neurons to brain networks, to cognition and behaviour, addressing the healthy and diseased brain. Through research and training from top-class scientists and close...

Funding Programme
Start Date
End Date
Total Funding
€ 3 961 160
European Countries Involved

MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure

CRUCIAL

Vascular dementia and heart failure represent major health burden to morbidity, mortality and quality of life. Comorbidities (hypertension, aging, diabetes, etc.) affect all organs, but the brain and heart are especially sensitive to these chronic stresses resulting in cognitive impairment (a mental disorder) and heart failure (a non-mental...

Funding Programme
Start Date
End Date
Total Funding
€ 6 000 000
European Countries Involved

Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics

MITOTARGET

Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where...

Funding Programme
Start Date
End Date
Total Funding
€ 10 332 038
European Countries Involved

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

MIRIADE

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression. With its...

Funding Programme
Start Date
End Date
Total Funding
€ 4 034 565

Multimedia technology for independence and participation for people with dementia

MYLIFE

The objective of Mylife is to support independence for older people with reduced cognitive function by giving them access to simple and intuitive services that are adapted to their individual needs and wishes. The ambition of the Mylife project is to provide network-based access to, and management of, commercially and/or freely available software...

Funding Programme
Start Date
End Date
Total Funding
€ 1 059 973
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).